LYDIA MARTIN: Open Payments
NPI 1285022988 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 41 payments from 14 companies in 2025. Trend: 2023 $403 · 2024 $401 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $131 |
| Amgen Inc. | 6 | $116 |
| Lilly USA, LLC | 4 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Ardelyx, Inc. | 3 | $49 |
| Vifor Pharma, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: JARDIANCE, JYNARQUE, TAVNEOS, Kerendia, IBSRELA, Veltassa, SHINGRIX, Fabhalta.
Industry payments across DE — which companies pay providers there.
